GlaxoSmithKline (Switzerland)

Recent papers from GlaxoSmithKline (Switzerland)

1. ENTRÉE Lung: An Open-label Platform Study Investigating the Safety and Pharmacokinetics of Belrestotug Combinations in Advanced Non-Small Cell Lung CancerClinical Cancer Research · 2026
2. Cross-Plant Monitoring Model Transfer for Fed-Batch mAb Production under Limited Target DataIndustrial & Engineering Chemistry Research · 2026
3. Uncovering lung virome signatures of COPD severity and acute exacerbations in longitudinally sampled AERIS cohortnpj Biofilms and Microbiomes · 2026
4. Belantamab mafodotin triggers immune invigoration in multiple myeloma via inflammatory and immunogenic cell deathBMJ Immunology · 2026
5. Genetic characterization of M. tuberculosis isolates from participants in a Phase 2b randomized trial evaluating the M72/AS01E tuberculosis candidate vaccineThe Journal of Infectious Diseases · 2026
6. A Phase 1 First-Time-in-Human, Open-Label Study of Nelistotug Administered to Patients with Advanced Solid TumorsClinical Cancer Research · 2026
7. Total-body PET of two approved PARP inhibitors: [18F]Olaparib and [11C]Niraparib in Non-Human PrimatesEJNMMI Radiopharmacy and Chemistry · 2026
8. Fast and accurate point surveying using the PIX4Dcatch mobile appISPRS annals of the photogrammetry, remote sensing and spatial information sciences · 2026
9. Refining drug screening with automated home cage monitoring: a crossover study in socially housed ratsFrontiers in Toxicology · 2026
10. Spectroscopy-Based Cell Culture Predictive MonitoringBioTech · 2026
11. Safety and immunogenicity of one or two additional doses of the adjuvanted recombinant zoster vaccine administered 5–6 years after primary vaccination in adults ≥50 yearsOpen Forum Infectious Diseases · 2026
12. Comprehensive genomics, systems, and structural assessment for novel target identification in penicillin-resistant Streptococcus pneumoniaeFrontiers in Bioinformatics · 2026
13. Prospective ICH Q2(R2)-Aligned Total-Error Validation of Label-Free Untargeted Proteomics for Host Cell Protein Quantification in BiotherapeuticsProteomes · 2026
14. The role of innovative financing to bridge the gap between implementation and commercialisationMalaria Journal · 2026
15. Leveraging analytical and bioprocess platforms for biological product development and commercialization – A meeting reportBiologicals · 2026
16. COPD Exacerbation Recognition Tool: Translation, Linguistic, and Cross-Cultural ValidationChronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 2026
17. Maximizing impact: the power of early HPV vaccination for long-term protection―lessons from a systematic review and meta-regression analysisJournal of Public Health · 2026
18. Evaluation of high-throughput sequencing for replacing the conventional adventitious virus detection assays used for biologicsnpj Vaccines · 2025
19. Holistic approach to dysmenorrhea management: Integrating pharmacological and non-pharmacological interventions for improved women’s health in the Middle East and AfricaBMC Women s Health · 2025
20. Holistic approach to dysmenorrhea management: Integrating pharmacological and non-pharmacological interventions for improved women’s health in the Middle East and AfricaBMC Women s Health · 2025